Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 8월 30

Xtant Medical Holdings Inc

XTNTAMEX
Trade with Public
Trade with Public
$0.3840
0.05416.36%
가까이에: Aug 28, 5:00 PM EST
$0.3651
-0.0189-4.92%
시간외: Aug 28, 7:59 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Xtant Medical Holdings Financials

Xtant Medical Holdings (XTNT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 250 percent decrease over earnings of $0.02 per share from
Benzinga Newsdesk

PRO
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M Est

Xtant Medical Hldgs (AMEX:XTNT) lowers FY2026 sales outlook from $101.000 million-$105.000 million to $99.000 million-$103.000 million vs $102.058 million estimate.
Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
Xtant Medical Raises FY2026 Sales Guidance from $95.000M-$99.000M to $101.000M-$105.000M vs $96.725M Est

2026 Financial GuidanceThe Company is today increasing its full-year 2026 revenue guidance to a range of $101 million to $105 million, from $95 million to $99 million previously, to reflect the recently announced
Benzinga Newsdesk

PRO
Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.884 million which beat the analyst consensus estimate
Benzinga Newsdesk

PRO
Xtant Medical Hldgs Sees FY2026 Sales $95.000M-$99.000M vs $110.100M Est

Xtant Medical Hldgs (AMEX:XTNT) sees FY2026 sales of $95.000 million-$99.000 million vs $110.100 million analyst estimate.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved